The Role of the Cancer Center When Using Lymph Node Count as a Quality Measure for Gastric Cancer Surgery

Authors:

Abstract
Although it has been 15 years since the Institute of Medicine1 released a landmark report addressing the quality of cancer care in the United States, their most recent publication, Delivering High-Quality Cancer Care, admonishes barriers to quality-care delivery and concludes that “the cancer care delivery system is in crisis.”2 Among updated recommendations, the Institute of Medicine supports developing a national quality-reporting program with the support of professional societies using quality measures that are directly linked to outcomes. Established in 1922 by the American College of Surgeons, the Commission on Cancer (CoC) accredits hospitals with cancer programs that demonstrate adherence to continuously updated quality standards, mandated data reporting to the National Cancer Database, and periodic self-assessment and site visits. Institutions accredited by the CoC include more than 1500 US cancer programs that provide care to approximately 70% of the patients with newly diagnosed cancer in the nation.3,4 Likewise, the National Cancer Institute (NCI) developed the framework for its network of cancer centers after passage of the National Cancer Act in 1971. The 68 cancer centers in the United States that currently carry NCI designation of a cancer center or comprehensive cancer center have met stringent criteria for basic science–, clinical-, and population-based research, training, and outreach designed to provide the public with efficient access to translational medicine for cancer care.5 Inherent in the mission of the CoC and NCI programs is an imperative to improve the quality of cancer care.

This publication has 11 references indexed in Scilit: